Shanghai Beitongji Biotechnology Co.
Latest round
- Series C
Last raised
- May 2023
Total raised
- $90M
Investors
- 11
About Shanghai Beitongji Biotechnology Co.
Established in 2014 and based in Shanghai, China, Shanghai Bioengine Technology is a biotech company that focuses on the development and production of biopharmaceutical products. The firm has over 200 partners, including CSPC, BGI, Boan Biotech, etc. As of 2023, it has 108 employees. In 2015, the company launched a serum-free medium for MDCK cells. In 2016, the company built its Zhangjiang base. In 2017, the company launched a low serum medium for BHK cells. In 2021, the Phase II culture media production base commenced full operation. The company engages in the development of animal cell culture media. BioEngine has developed nearly 100 types of serum-free media for different cell lines, including Eden series serum-free medium for CHO cells, HIPP series serum-free medium for immune effector cells for cell therapy, serum-free medium for vaccine production of Vero, etc, which are suitable for antibodies, vaccines, and cell and gene therapy (CGT) fields. BioEngine has supported more than 80 clinical projects in the biopharma industry and has provided nearly 100 cell culture technology services. It provides one-stop services from cell culture process development and optimization, and medium formulation design to medium processing and manufacturing for biopharmaceutical companies and organizations.
Who invested in Shanghai Beitongji Biotechnology Co.
11 investors across 4 rounds
See all investors in Shanghai Beitongji Biotechnology Co.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Shanghai Beitongji Biotechnology Co.
Who invested in Shanghai Beitongji Biotechnology Co.?
Shanghai Beitongji Biotechnology Co. has 11 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Shanghai Beitongji Biotechnology Co. raised?
Shanghai Beitongji Biotechnology Co. has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did Shanghai Beitongji Biotechnology Co. last raise money?
Shanghai Beitongji Biotechnology Co.'s most recent round on record is a Series C, in May 2023.
What does Shanghai Beitongji Biotechnology Co. do?
Established in 2014 and based in Shanghai, China, Shanghai Bioengine Technology is a biotech company that focuses on the development and production of biopharmaceutical products.
Where is Shanghai Beitongji Biotechnology Co. headquartered?
Shanghai Beitongji Biotechnology Co. is headquartered in Shanghai, China.
Which VCs invest in companies like Shanghai Beitongji Biotechnology Co.?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Shanghai Beitongji Biotechnology Co.'s stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Shanghai Beitongji Biotechnology Co.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.